Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?

Michael Pan, Ranjith Ramasamy, Jason R. Kovac

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A semen analysis (SA) should be performed on all men of reproductive age prior to the commencement of testosterone supplementation therapy (TST). A baseline SA has numerous benefits including the ability to unmask occult azoospermia, act as a baseline measure of reproductive function, and provide a recovery target for management of TST-induced testicular dysfunction. Physicians treating men of reproductive age with TST should incorporate SA as part of their initial treatment protocol.

Original languageEnglish (US)
Pages (from-to)446-447
Number of pages2
JournalJournal of the Canadian Urological Association
Volume8
Issue number11-12 DECEMBER
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Semen Analysis
Testosterone
Azoospermia
Clinical Protocols
Therapeutics
Physicians

Keywords

  • Fertility preservation
  • Hypogonadism
  • Semen analysis
  • Testosterone supplementation therapy

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age? / Pan, Michael; Ramasamy, Ranjith; Kovac, Jason R.

In: Journal of the Canadian Urological Association, Vol. 8, No. 11-12 DECEMBER, 01.12.2014, p. 446-447.

Research output: Contribution to journalArticle

@article{c1bae33fd7de4af5989fee9a92227733,
title = "Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?",
abstract = "A semen analysis (SA) should be performed on all men of reproductive age prior to the commencement of testosterone supplementation therapy (TST). A baseline SA has numerous benefits including the ability to unmask occult azoospermia, act as a baseline measure of reproductive function, and provide a recovery target for management of TST-induced testicular dysfunction. Physicians treating men of reproductive age with TST should incorporate SA as part of their initial treatment protocol.",
keywords = "Fertility preservation, Hypogonadism, Semen analysis, Testosterone supplementation therapy",
author = "Michael Pan and Ranjith Ramasamy and Kovac, {Jason R.}",
year = "2014",
month = "12",
day = "1",
doi = "10.5489/cuaj.2259",
language = "English (US)",
volume = "8",
pages = "446--447",
journal = "Journal of the Canadian Urological Association",
issn = "1911-6470",
publisher = "Canadian Medical Association",
number = "11-12 DECEMBER",

}

TY - JOUR

T1 - Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?

AU - Pan, Michael

AU - Ramasamy, Ranjith

AU - Kovac, Jason R.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - A semen analysis (SA) should be performed on all men of reproductive age prior to the commencement of testosterone supplementation therapy (TST). A baseline SA has numerous benefits including the ability to unmask occult azoospermia, act as a baseline measure of reproductive function, and provide a recovery target for management of TST-induced testicular dysfunction. Physicians treating men of reproductive age with TST should incorporate SA as part of their initial treatment protocol.

AB - A semen analysis (SA) should be performed on all men of reproductive age prior to the commencement of testosterone supplementation therapy (TST). A baseline SA has numerous benefits including the ability to unmask occult azoospermia, act as a baseline measure of reproductive function, and provide a recovery target for management of TST-induced testicular dysfunction. Physicians treating men of reproductive age with TST should incorporate SA as part of their initial treatment protocol.

KW - Fertility preservation

KW - Hypogonadism

KW - Semen analysis

KW - Testosterone supplementation therapy

UR - http://www.scopus.com/inward/record.url?scp=84919926837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919926837&partnerID=8YFLogxK

U2 - 10.5489/cuaj.2259

DO - 10.5489/cuaj.2259

M3 - Article

AN - SCOPUS:84919926837

VL - 8

SP - 446

EP - 447

JO - Journal of the Canadian Urological Association

JF - Journal of the Canadian Urological Association

SN - 1911-6470

IS - 11-12 DECEMBER

ER -